Content by user

Implanted Intrathecal Pain Pumps

Allyson Fonte's picture


Is anyone performing these procedures able to share their policy with me? We have interventional pain specialists that would like the ability to offer this treatment to potential candidates, so we are in the process of operationalizing (order sets, education, policy, etc.). Any information anyone could share would be greatly appreciated!

Insulin floor stock

Samar Nicolas's picture


I was wondering how other hospitals handle insulin vials on the nursing units? how/where is it stored? we currently send vials up to nursing units as a floor stock and label them with a 28 days expiration date once they leave the pharmacy. There is no consistent process on the nursing units as to having a designated place to store insulin. Nurses often take the vials and not return them to a designated place. they end up asking for more vials to be sent up. We sometimes find several open vials of the same insulin that are expired and need to be wasted.

Cleaning of the Hazardous Sterile Compounding Room

Sarah Katherine Gallup's picture


We are currently in the process of changing to having our pharmacy staff clean our compounding suites instead of EVS and I am re-writing the standards of operations surrounding this process. When cleaning the hazardous room (just the daily floor cleaning do you have staff fully gown up with chemotherapy gowns/gloves or do they just wear the regular disposable clean room gown and gloves?

Thank you!
Sarah Gallup

Xolair Monitoring

Emily Kay D'Anna's picture


Hi there!

I wondered if anyone had any protocols or guidelines in your ambulatory spaces regarding monitoring / observation recommendations following administration of Omalizumab (Xolair®) in the outpatient or infusion center setting?

Thanks so much in advance,


Monoclonal Antibody handling

Emily Kay D'Anna's picture



Our institution has started a discussion around what PPE and preparation precautions should be in place for monoclonal antibodies (in both the inpatient and ambulatory setting). We recognize that the only monoclonal antibodies that fall on the NIOSH hazardous drug list include those that are conjugated to an antineoplastic (eg, gemtuzumab)... whereas other commonly used mAbs (eg, infliximab, omalizumab-outpatient) are not present in the list. (I did attach two articles that leaned towards treating these agents as hazardous medications.)

Vivitrol, Revia, Suboxone and opiates

Dan Sheridan's picture



We're trying to develop a good process for handling patients who are struggling with an opiate addiction and are on oral or injectable naloxone or Suboxone therapy. Specifically, how do we identify these patients? How do we treat them where they are under our care? How do we avoid discharging them on opiates?

Have any of you addressed this issue? Can you share your processes?

Thank you,

Medication error rate KPI

Oudah Alabdali's picture


Dear Colleagues,

Hope you are doing great
As you all know, every healthcare organization has it's own KPI ( key performance indicator ) for medication error rate followup which aim to control medication errors among the hospital and help to prevent recurrence of incidents, my inquiries about if you have formula or equation to determine the internal target of medication error rate that you will achieve it quarterly or monthly ( regarding the international target is it 2% - 14% ). Any participation will be highly appreciable. Thanks